RxDoctor Payments Data

Jose Uribe, MD

Otolaryngology/Facial Plastic Surgery · Bethlehem, PANPI 1962660266

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,008, 2.3 times the $441 reported in 2019.

$3,595in general payments, 2019–2025

Across 113 payments — averaging $31.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$545
  • GSK$527
  • Neurent Medical Limited$523
  • Medtronic$408
  • Phathom Pharmaceuticals, Inc.$272
  • Intersect ENT, Inc.$241
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,595 in reported general payments places this provider in the 55th percentile of 21 otolaryngology/facial plastic surgery providers in Pennsylvania.

See all otolaryngology/facial plastic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$60,938
Medicare patients
198
Services billed
519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,912
Fluticasone Propionate86$821
Pantoprazole Sodium65$438
Ofloxacin17$362
Ipratropium Bromide11$238
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$99
Mupirocin12$78
Famotidine17$52

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Bethlehem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →